Search Orphan Drug Designations and Approvals
-
Generic Name: | Humanized IgG-1 antibody targeting human transferrin receptor conjugated to human iduronate-2-sulfatase |
---|---|
Date Designated: | 10/15/2018 |
Orphan Designation: | Treatment of Mucopolysaccharidosis Type II (MPS II) or Hunter Syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
JCR Pharmaceuticals Co., Ltd. 2-4 Kasuga-cho Ashiya, Hyogo Prefecture Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-